Peter T.P. Bye
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 7
-
- Cystic Fibrosis Research Advances 52
- Tracheal and airway disorders 13
- Neonatal Respiratory Health Research 11
- Respiratory Support and Mechanisms 9
- Inhalation and Respiratory Drug Delivery 6
- Endocrinology top 5%
- Speech and Hearing top 2%
-
- Bacterial biofilms and quorum sensing 12
-
- Asthma and respiratory diseases 9
Peter T.P. Bye
67 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Medicine 318
- Pulmonary and Respiratory Medicine 1.9k
- Endocrinology 111
- Speech and Hearing 133
- Critical Care and Intensive Care Medicine 61
Countries citing papers authored by Peter T.P. Bye
This map shows the geographic impact of Peter T.P. Bye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter T.P. Bye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter T.P. Bye more than expected).
Fields of papers citing papers by Peter T.P. Bye
This network shows the impact of papers produced by Peter T.P. Bye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter T.P. Bye. The network helps show where Peter T.P. Bye may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter T.P. Bye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 55 | |
| 2 | 2016 | 33 | |
| 3 | Continuous Glucose Monitoring As A Useful Decision-Making Tool For Adults With Cystic Fibrosis | 2014 | 1 |
| 4 | 2014 | 22 | |
| 5 | 2012 | 50 | |
| 6 | 2012 | 10 | |
| 7 | 2012 | 18 | |
| 8 | 2011 | 4 | |
| 9 | 2011 | 39 | |
| 10 | 2011 | 41 | |
| 11 | 2009 | 56 | |
| 12 | 2008 | 117 | |
| 13 | 2006 | 68 | |
| 14 | 2005 | 78 | |
| 15 | 2005 | 63 | |
| 16 | 2004 | 32 | |
| 17 | IT Architectures and Middleware: Strategies for Building Large, Integrated Systems (2nd Edition) | 2004 | 14 |
| 18 | 2004 | 23 | |
| 19 | 2002 | 12 | |
| 20 | 1992 | 18 |
About Peter T.P. Bye
Peter T.P. Bye is a scholar working on Pulmonary and Respiratory Medicine, Molecular Medicine and Endocrinology, having authored 67 papers that have together received 2.5k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (52 papers), Tracheal and airway disorders (13 papers), Bacterial biofilms and quorum sensing (12 papers), Neonatal Respiratory Health Research (11 papers), Respiratory Support and Mechanisms (9 papers), Asthma and respiratory diseases (9 papers), Antibiotic Resistance in Bacteria (7 papers) and Inhalation and Respiratory Drug Delivery (6 papers). The work is most often cited by research in Molecular Medicine (318 citations), Pulmonary and Respiratory Medicine (1.9k citations) and Endocrinology (111 citations). Peter T.P. Bye has collaborated with scholars based in Australia, United Kingdom and Canada. Frequent co-authors include Mark R. Elkins, Barbara Rose, Colin Harbour, Michael Robinson, C. Moriarty, Guy B. Marks, Elena G. Belousova, Wei Xuan, Scott C. Bell and Catherine J. Dobbin. Their work appears in journals such as Journal of Cystic Fibrosis, BMC Pulmonary Medicine, European Respiratory Journal, Journal of Clinical Microbiology and Respirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.